June 18, 2012
Recorded: March 27, 2012
Many patients with cardiovascular disease, especially heart-failure patients and patients with ACS, are on multiple medications. Do all these drugs really work—and work well—with each other?
Dr James Stein sits down with Drs Bob Harrington and Harlan Krumholz to discuss why it may be time to drop some medications and the kind of clinical trials that need to be done to help us decide which ones.
Recorded: March 27, 2012
Many patients with cardiovascular disease, especially heart-failure patients and patients with ACS, are on multiple medications. Do all these drugs really work—and work well—with each other?
Dr James Stein sits down with Drs Bob Harrington and Harlan Krumholz to discuss why it may be time to drop some medications and the kind of clinical trials that need to be done to help us decide which ones.
Chair
James Stein MD
Professor of Medicine
University of Wisconsin School of Medicine and Public Health
Madison, WI
Dr Stein serves as a member of data safety and monitoring committees for clinical trials sponsored by Abbott Laboratories, Eli Lilly, and Takeda. He has received royalties from Wisconsin Alumni Research Foundation.
Professor of Medicine
University of Wisconsin School of Medicine and Public Health
Madison, WI
Dr Stein serves as a member of data safety and monitoring committees for clinical trials sponsored by Abbott Laboratories, Eli Lilly, and Takeda. He has received royalties from Wisconsin Alumni Research Foundation.
Panelists
Harlan Krumholz MD
Harold H Hines Jr Professor of Medicine (Cardiology)
Director, Clinical Scholars Program
Yale University
Director, Yale-New Haven Hospital Center for Outcomes Research and Evaluation
New Haven, CT
Dr Krumholz has no relevant financial disclosures to report.
Bob Harrington MD
Richard Sean Stack MD Distinguished Professor, Division of Cardiology
Department of Medicine Director
Duke Clinical Research Institute
Durham, NC
To view Dr Harrington's disclosures, click here.
Harold H Hines Jr Professor of Medicine (Cardiology)
Director, Clinical Scholars Program
Yale University
Director, Yale-New Haven Hospital Center for Outcomes Research and Evaluation
New Haven, CT
Dr Krumholz has no relevant financial disclosures to report.
Richard Sean Stack MD Distinguished Professor, Division of Cardiology
Department of Medicine Director
Duke Clinical Research Institute
Durham, NC
To view Dr Harrington's disclosures, click here.
Related Links:
-
Treat risk and not LDL-cholesterol targets, new perspective argues
[Clinical Conditions > Lipid/Metabolic; Jan 19, 2012] - Cutting copays for post-MI drugs helps outcomes, with no added cost to insurers
[Clinical Conditions > Acute Coronary Syndromes; Nov 14, 2012] - Caution against standard HF meds urged in very elderly with preserved-EF heart failure
[Clinical Conditions > Heart failure; Mar 16, 2009]
